You are here

Lexaria Bioscience Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
LXX
CSE Index: 
Currency: 

Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company’s technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH increases bio-absorption by up to 5-10x, reduces time of onset from 1 - 2 hours to 10 - 20 minutes, and masks unwanted tastes for orally administered bioactive molecules, including anti-virals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine, and other molecules. Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles, and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide.

 

You are here

Lexaria Bioscience Corp. (LXX)

SEDAR Information

Company Info

Address
#100 - 740 McCurdy Rd.,
Kelowna, BC V1X 2P7
Canada
Phone
1-250-765-6424
Fax
1-250-765-2599
Email
cbunka@lexariabioscience.com
Website
http://www.lexariabioscience.com
Listing date
Wednesday, October 28, 2009
Transfer Agent
Computershare Investor Services Inc.
Auditor
Davidson & Company LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
80,720,879
Reserved for Issuance: 
10,285,820

Company Officers

Chris Bunka, CEO
John Docherty, President
Allan Spissinger CPA, CA, CFO

Bulletins

10/05/2016

2016-0507 – Name Change - Lexaria Corp. (LXX)

 

Lexaria Corp. has announced a name change to Lexaria Bioscience Corp.

Shares will begin trading under the new name on Thursday, May 12, 2016.

Disclosure documents are available www.thecse.com

Please note the CUSIP, ISIN and symbol will remain the same.

Effective Date: May 12, 2016

If you have any questions or require further information, please contact Listings at (416) 367-7340 or E-mail:  Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-10-27-TT-Website_V2_1.png

Tech Tuesdays

Tuesday, October 27, 2020 -
4:15pm to 5:00pm
2020-11-04-84th-Annual-STANY-Conference_Website_1.png

84th Annual STANY Conference

Wednesday, November 4, 2020 -
12:00pm to 6:00pm
ipP_rRhg_1.png

Mining Over Canada

Tuesday, November 24, 2020 -
1:00pm to 4:00pm